Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

NCT05854667 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Methamphetamine Abuse
Methamphetamine-dependence
Addiction, Substance
Addiction

Interventions

DRUG: Treatment as Usual plus Placebo
DRUG: Treatment as Usual plus Placebo plus Contingency Management
DRUG: Treatment as Usual plus lisdexamfetamine (LDX-01)
DRUG: Treatment as Usual plus lisdexamfetamine (LDX-01) plus Contingency Management

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]